T Cell Hybridomas. The T cell hybridoma FS 11.155 was prepared by fusion of Con A-stimulated T cell blasts from a B10.Q (H-2 q, Mls b) mouse spleen to the T cell tumor, BW5147, by previously described methods (4) . This hybridoma responded to spleen cells from all Mlsa'd-positive strains tested (DBA/2, CBA/J, NZB, AKR/J, D1.LP, and SM/J). The second hybridoma described, BD10.42, was the product of a fusion of the T cell clone, DI0.2 (described above), to BW5147 using the same procedures. Subclones of hybridomas were prepared by recloning at limiting dilution.
Interleukin 2 (IL-2)Assay. Using standard procedures (4), hybridomas (1-2 × 105 cells)
were assayed for their ability to produce IL-2 when stimulated with 5 × l0 s irradiated (1,500 rad) spleen cells bearing the appropriate MHC or Mls haplotype. 24-48 h later, 100 #l of medium was removed and added to 100 #l medium containing 4,000 HT.2 cells (5) or CTLL-2-15H cells (derived originally by Drs. P. Baker, S. Gillis, and K. Smith, Dartmouth Medical School); we used these only once (line 1 of Table I ). The cultures were pulsed 24 h later with [SH]thymidine, harvested, and counted 18 h afterwards. With a 1:4 dilution of rat Con A SN, HT-2 or CTLL cells incorporated 60,000-100,000 cpm. Cultured alone, these indicator cells took up <500 cpm.
Results
Experimental Approach. T cell hybridomas are karyotypicaily unstable and lose chromosomes for some period of the time after fusion (6) . Hence, if the recognition structures for T cell responses to Mls and H-2 determinants were encoded on the same chromosome, then loss of reactivity to Mls determinants by chromosome loss should also be accompanied by loss of H-2 responsiveness, and vice versa. Conversely, if these receptor structures were encoded on different chromosomes, then some hybridoma clones should show Mls reactivity but lack H-2 reactivity, and vice versa.
To test these predictions we prepared two different T cell hybridomas with dual specificity for Mls a'a and allo-H-2 determinants. The hybridomas were repeatedly subcloned by limiting dilution. After each round of cloning 30-100 hybrids were tested for their ability to secrete IL-2 when triggered with Mls-or with H-2-disparate stimulator cells.
Loss of Mls Reactivity. The first hybridoma, FS 11.155, showed strong reactivity in IL-2 assays to H-2 d stimulators and weaker, but significant responses to Mls a'a stimulators (Table I) . Subclones of this hybridoma showed three different reactivity patterns, represented in Table I . Some (e.g., FS 11.155.14) responded well to both MIs ~'a and H-2 a, some (e.g., FS11.155.16) responded only to H-2 a but lacked reactivity to Mls a'a (Table I) , and others (e.g., FS11.155.12) reacted with neither H-2 nor Mis determinants. See Table I . * Subclones shown were picked from plates that had 24 out of 96 wells positive for growth.
The dual-reactive hybridoma clone FS 11.155.14 was further subcloned; 23 of 39 subclones maintained dual reactivity for Mls and H-2, four of 39 lacked both reactivities, and 10 of 39 could be stimulated only with H-2 d stimulators. ~ Representative subclones of these three groups are described in Table II . Fig. 1 summarizes the results obtained with cloning of the FS11.155 hybridoma. Two points seem evident: (a) the proportion of subclones showing only H-2 responses dropped from -50% (15/33) in the first round of cloning to 5% (3/65) in the third round; while (b) the proportion of dual-reactive clones increased from 50% (14133) to ~85% (54/65). Evidently, the FSl1.155 hybridoma became more stable karyotypically during the process of sequential subcloning.
Loss of H-2 Reactivity. The second hybridoma, BD10.42, was obtained from a fusion of BW5147 with a T cell clone, D10.2, expressing dual specificity for MIs a'd and H-2 p (Materials and Methods). At the time of fusion, D 10.2 (a subclone of parental clone D10) was further subcloned; all 20 subclones showed dual reactivity for Mls a'd and H-2 p. After fusion, the hybridoma BD10 proved to be so unstable that three rounds of sequential subcloning were required to derive a definitive assessment of specificity in IL-2 assays. Typical specificity patterns that emerged after these repeated subclonings are shown in Table III See Table I . * Subclones were picked from plates that had 18 out of 96 wells positive for growth.
The other subclones tested had a similar reactivity pattern. at FD 13,4.3. I la3 is an independently derived T cell hybridoma used in this experiment as a positive control for the B10.P stimulator cells.
subclones (e.g., BD10.42.20.65) reacted with both Mls a'd and H-2 p. Others responded to neither stimulator (not shown). Some, like BD10.42.9.5, showed no reactivity to H-2 p and strong reactivity to Mlsa'a; the specificity patterns of five representative subclones derived from BD 10.42.9.5 are shown in Table I II. The clones exemplified in Table III showed the same specificity pattern in four separate experiments performed over a 6-mo period.
Expression of the L3T4 Marker. The mouse T cell surface molecule L3T4, defined by monoclonal antibody GK1.5 (3), is thought to be involved in raising the avidity with which T cells react with antigen (7). It was therefore of interest to know whether the loss of only one of the two antigen specificities by the T hybridomas would correlate with the loss of the L3T4 molecule. No evidence could be found for such an association. Both sets of hybridomas (FS11.155 and BD10.42) were initially L3T4 +, as assessed by FACS analysis with the antibody GK1.5 (data not shown). All of the BD10.42-derived hybridomas retained the expression of L3T4, despite repeated subcloning. In marked contrast, all of the FS 11.155-derived hybridomas were negative for L3T4 after the third subcloning, irrespective of their specificity. Loss of the L3T4 marker is thus an unlikely explanation for the above results. Discussion Using karyotypically unstable T cell hybridomas, we demonstrate here that dual-reactive hybridomas specific for MIs a'a and allo-H-2 determinants generate variants which no longer respond to one of these sets of stimulating determinants, but continue to respond to the other set. The simplest explanation for this observation is that Mls and H-2 determinants are recognized by different sets of receptor structures, encoded on different chromosomes. In this case, loss of the chromosome that encodes receptors with anti-MIs reactivity would not affect anti-H-2 reactivity, and vice versa.
Alternatively, one could postulate some mutational event that modifies the receptor only slightly, such that it will still react with one ligand but not the other. This mutation would have to have several unusual characteristics. For example, it would have to occur with an unusually high frequency during the first 1-2 mo after fusion, since each round of subcloning during this time generated a significant proportion of new clones lacking one reactivity. The mechanism operative in generating such mutations would then cease within a few months after fusion, since after this time we were rarely able to find new clones lacking one reactivity. The majority of the subclones obtained from late cloning rounds either maintained both reactivities or lost both. Those which lost both reactivities were rather frequent, perhaps reflecting defective synthesis or secretion of IL-2. Dual-reactive hybridomas derived soon after fusion often show reactivity patterns in which there is high reactivity to one set of determinants, and intermediate or low reactivity to the other (e.g., FSl1.155 in Table I ). Although such findings are clearly suggestive of mutation, to date, all attempts to obtain stable hybrids with this specificity have failed. In our hands, further subcloning of the hybridomas invariably generates a mixture of two reactivity patterns (in addition to nonreactive hybridomas): some hybridomas show high reactivity to both sets of determinants, while others react only to one and not the other sets of determinants (see Table I ).
For the above reasons, and because of the current lack of evidence for somatic mutation in T cell receptors (8) , chromosome loss would seem to be the most likely explanation for the data. Mutations certainly cannot be ruled out, however, and it is quite possible that chromosome loss and/or somatic mutation occur. A clear distinction between the above two explanations must await a more detailed characterization of T cell receptors at the molecular level.
One question raised by these results is why only loss of Mls reactivity occurred with the FS11.155 hybridoma and only H-2 reactivity was lost with the BD10.42 hybridoma. This result may indicate the occurrence of predisposing chromo-somal events in the immediate postfusion period that dictate which chromosomes can be subsequently lost without compromising the viability of the cell, or its capacity to synthesize and secrete IL-2.
If recognition of Mls determinants is indeed controlled by a separate set of receptors, what is the biological significance of Mls determinants? Although several possibilities have been suggested (9, 10), our current view is that, since Mls molecules are expressed predominantly on B cells, Mls molecules might function as accessory structures on B cells, increasing the overall avidity of T cells reactive with antigen on these cells, or perhaps allowing the production of a B cell lymphokine.
Summary
Previous studies have shown that T cell clones specific for strong Mls a'd determinants concomitantly display apparently random reactivity to allo-H-2 determinants. One explanation for this finding is that T cell recognition of Mls a'd and allo-H-2 determinants is controlled by separate sets of receptors. If these receptors were chromosomally unlinked, karyotypically unstable T cell hybrids with dual reactivity for Mls a'd and particular allo-H-2 determinants would be expected, occasionally, to lose reactivity for one set of determinants, but not the other. The results presented here provide direct support for this prediction. 2 October 1984. 
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